Aditxt, Inc. to Acquire Evofem Biosciences, Inc. to Build a Global Women’s Health Platform

Aditxt, Inc. (via Adifem, Inc.) to Merge with Evofem Biosciences, Inc.

November 6, 2024

Healthcare Services

Evofem Biosciences announced it has secured voting agreements from certain Series E-1 stockholders and convertible noteholders to approve its proposed merger with Aditxt’s subsidiary, Adifem, Inc., under an amended and restated merger agreement. The deal would result in Evofem merging into and becoming a wholly owned subsidiary of Aditxt (with the surviving entity described as Evofem). Closing is subject to conditions including stockholder approval and Aditxt raising sufficient capital for approximately $17 million in cash payments (including funding a senior secured noteholder).

Aditxt Signs Share Exchange Agreement to Acquire AiPharma Global Holdings

December 28, 2021

Healthcare Services

Aditxt (Nasdaq: ADTX) signed a share exchange agreement to acquire AiPharma Global Holdings LLC (AiPharma Global) in a two-step transaction involving an initial closing and a secondary closing, subject to conditions including regulatory, board, shareholder, and Nasdaq approvals. The deal would give Aditxt 9.5% of AiPharma at the initial closing and the remaining 90.5% at the secondary closing, with cash payments and Aditxt share issuance at each step.

Aditxt Acquires Appili Therapeutics

October 10, 2024

Healthcare Services

Aditxt, Inc. announced that Appili Therapeutics shareholders will vote on a proposed acquisition of all issued and outstanding shares of Appili through a plan of arrangement. Appili’s board recommended shareholders vote in favor, and Aditxt intends to use Appili’s infectious disease pipeline (including the FDA-approved LIKMEZ) to expand its reach in combating life-threatening infections and biodefense threats.

Fujirebio Acquires ADx NeuroSciences

June 23, 2022

Healthcare Services

Fujirebio, through its wholly owned subsidiary Fujirebio Europe NV, announced the acquisition of ADx NeuroSciences for €40 million. The deal is expected to close in July 2022, subject to customary closing conditions.

FemTec Health Acquires Nutrimedy

July 25, 2022

Healthcare Services

FemTec Health has acquired Nutrimedy, an evidence-based clinical nutrition platform that offers AI-enabled photo food recognition and support for 50+ medical conditions. The acquisition adds real-time, personalized nutrition and dietitian access to FemTec's Awesome Woman subscription suite, expanding the company's women's-health capabilities.

EQT X to Acquire Adalvo (B2B Generic Drug Dossiers)

July 18, 2025

Healthcare Services

EQT X (EQT) has agreed to acquire a majority stake in Adalvo, an asset-light B2B dossier developer that produces market-approval-ready generic drug dossiers for pharmaceutical companies. Existing shareholders, including Aztiq (holding company of Chairman Róbert Wessman), will reinvest part of their holdings and retain minority ownership. The deal is subject to customary approvals and is expected to close in H2 2025.